Additionally, S100A8/A9 interaction with RAGE activates NF-κB and MAPK signalling, leading to upregulation of chemokines, such as CXCL1, CLC5, and CLC7, resulting in the formation of a premetastatic niche and tumour progression [163]. Here, S100A8 is linked to neoplasm.